Skip to main content
Log in

Interaction of barbiturates with adenosine receptors in rat brain

  • Published:
Naunyn-Schmiedeberg's Archives of Pharmacology Aims and scope Submit manuscript

Summary

The effects of barbiturates on radioligand binding to inhibitory R i adenosine receptors of rat brain membranes were investigated. Binding of the adenosine receptor agonist (−)N6-phenylisopropyl[3H]adenosine and the antagonist 1,3-diethyl-8-[3H]phenylxanthine was inhibited by several barbiturates. This inhibition was concentration-dependent and occurred in the range of pharmacologically effective concentrations. Pentobarbital was the most potent of the barbiturates tested with a K i of 92 μmol/l. The (+)isomers of hexobarbital and mephobarbital were more potent than the respective (−)isomers. Barbituric acid itself did not displace either radioligand in concentrations up to 1 mmol/l. The inhibitory effect of pentobarbital was reversed by a single wash of membranes preincubated with the barbiturate. The presence of pentobarbital caused a decrease of the affinity of the receptor for the antagonist radioligand but did not alter the number of binding sites, suggesting a competitive antagonism. The effects of pentobarbital on radioligand binding to the receptor were not changed by the presence of picrotoxinin nor by the absence of chloride ions. This indicates that they are not mediated via the picrotoxinin binding site. The barbiturates could not be classified as either agonists or antagonists at the R i adenosine receptor. The presence of GTP did not influence the inhibition of radioligand binding by pentobarbital; this is also observed for antagonists, whereas the affinity of agonists is markedly reduced by GTP. Binding of antagonists to the receptor is enthalpy-driven; the interaction of pentobarbital with the receptor was entropy-driven and the same was true for agonists. Thus, the interaction of pentobarbital with R i adenosine receptors of rat brain membranes differs from that of both adenosine agonists and antagonists. Our data suggest that R i adenosine receptors may be involved in the mediation of the effects of barbiturates.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

References

  • Bruns RF, Daly JW, Snyder SH (1980) Adenosine receptors in brain membranes: Binding of N6-cyclohexyl[3H]adenosine and 1,3-diethyl-8-[3H]phenylxanthine. Proc Natl Acad Sci USA 77:5547–5551

    Google Scholar 

  • Büch H, Grund W, Buzello W, Rummel W (1969) Narkotische Wirksamkeit und Gewebsverteilung der optischen Antipoden des Pentobarbitals bei der Ratte. Biochem Pharmacol 18:1005–1009

    Google Scholar 

  • Burnstock G, Brown CM (1981) An introduction to purinergic receptors. In: Burnstock G (ed) Purinergic receptors. Chapman and Hall, London, pp 1–45

    Google Scholar 

  • Cooper DMF, Londos C, Rodbell M (1980) Adenosine receptormediated inhibition of rat cerebral cortical adenylate cyclase by a GTP-dependent process. Mol Pharmacol 18:598–601

    Google Scholar 

  • De Lean A, Hancock AA, Lefkowitz RJ (1982) Validation and statistical analysis of a computer modeling method for quantitative analysis of radioligand binding data for mixtures of pharmacological receptor subtypes. Mol Pharmacol 21:5–16

    Google Scholar 

  • Ebersolt C, Prémont J, Bockaert J (1983) Inhibition of brain adenylate cyclase by A1 adenosine receptors: Pharmacological characteristics and locations. Brain Res 267:123–129

    Google Scholar 

  • Goodman RR, Cooper MJ, Gavish M, Snyder SH (1982) Guanine nucleotide and cation regulation of the binding of [3H]cyclohexyladenosine and [3H]diethylphenylxanthine to adenosine A1 receptors in brain membranes. Mol Pharmacol 21:329–335

    Google Scholar 

  • Hirsch MD (1983) Barbiturate competition for TRH receptors in mouse brain: neuromodulation of anesthesia. Peptides 4:255–260

    Google Scholar 

  • Ho IK, Harris RA (1981) Mechanism of action of barbiturates. Ann Rev Pharmacol Toxicol 21:83–111

    Google Scholar 

  • Houslay MD, Dipple I, Gordon LM (1981) Phenobarbital selectively modulates the glucagon-stimulated activity of adenylate cyclase by depressing the lipid phase separation occurring in the outer half of the bilayer of liver plasma membranes. Biochem J 197:675–681

    Google Scholar 

  • Jackisch R, Strittmatter H, Fehr R, Hertting G (1983) Modulation of hippocampal noradrenaline and acetylcholine release by endogenous adenosine. Naunyn-Schmiedeberg's Arch Pharmacol [Suppl] 324:R77

    Google Scholar 

  • Murphy KMM, Snyder SH (1982) Heterogeneity of adenosine A1 receptor binding in brain tissue. Mol Pharmacol 22:250–257

    Google Scholar 

  • Lohse MJ, Lenschow V, Schwabe U (1983) Interaction of barbiturates with adenosine receptors in rat brain. Naunyn-Schmiedeberg's Arch Pharmacol [Suppl] 324:R78

    Google Scholar 

  • Londos C, Cooper DMF, Wolff J (1980) Subclasses of external adenosine receptors. Proc Natl Acad Sci USA 77:2551–2554

    Google Scholar 

  • Lowry OH, Rosenbrough NJ, Farr AL, Randall RJ (1951) Protein measurement with the Folin phenol reagent. J Biol Chem 193:265–275

    Google Scholar 

  • Olsen RW (1982) Drug interactions at the GABA receptorionophore complex. Ann Rev Pharmacol Toxicol 22:245–277

    Google Scholar 

  • Phillis JW, Wu PH (1981) The role of adenosine and its nucleotides in central synaptic transmission. Prog Neurobiol 16:187–239

    Google Scholar 

  • Phillis JW, Wu PH (1983) The role of adenosine in central neuromodulation. In: Berne RM, Rall TW, Rubio R (eds) Regulatory function of adenosine. Martinus Nijhoff Publishers, The Hague Boston London, pp 419–437

    Google Scholar 

  • Prémont J, Perez M, Bockaert J (1977) Adenosine sensitive adenylate cyclase in rat striatal homogenates and its relationship to dopamine- and Ca2+-sensitive adenylate cyclases. Mol Pharmacol 13:662–670

    Google Scholar 

  • Schubert P, Lee K, Reddington M, Kreutzberg G (1983) Synaptic modulation by adenosine: Electrophysiological and biochemical characteristics. In: Berne RM, Rall TW, Rubio R (eds) Regulatory function of adenosine. Martinus Nijhoff Publishers, The Hague Boston London, pp 439–454

    Google Scholar 

  • Schwabe U, Trost T (1980) Characterization of adenosine receptors in rat brain by (−)[3H]N6-phenylisopropyladenosine. Naunyn-Schmiedeberg's Arch Pharmacol 313:179–187

    Google Scholar 

  • Snyder SH, Katims JJ, Annau Z, Bruns RF, Daly JW (1981) Adenosine receptors and behavioral actions of methylxanthines. Proc Natl Acad Sci USA 78:3260–3264

    Google Scholar 

  • Ticku MK, Olsen RW (1978) Interaction of barbiturates with dihydropicrotoxinin binding sites related to the GABA receptor-ionophore system. Life Sci 22:1643–1652

    Google Scholar 

  • Van Calker D, Müller M, Hamprecht B (1978) Adenosine inhibits the accumulation of cyclic AMP in cultured brain cells. Nature 276:839–841

    Google Scholar 

  • Walström G (1966) Differences in the anaesthetic properties between the optical antipodes of hexobarbital in the rat. Life Sci 5:1781–1790

    Google Scholar 

  • Weiland GA, Minnemann KP, Molinoff PB (1979) Fundamental difference between the molecular interactions of agonists and antagonists with the β-adrenergic receptor. Nature 281: 114–117

    Google Scholar 

  • Whittaker VP (1969) The synaptosome. In: Lajtha A (ed) Handbook of neurochemistry, vol 2. Plenum Press, New York, pp 327–364

    Google Scholar 

  • Williams M, Risley EA (1980) Biochemical characterization of putative central purinergic receptors by using 2-chloro[3H]-adenosine, a stable analog of adenosine. Proc Natl Acad Sci USA 77:6892–6896

    Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Rights and permissions

Reprints and permissions

About this article

Cite this article

Lohse, M.J., Lenschow, V. & Schwabe, U. Interaction of barbiturates with adenosine receptors in rat brain. Naunyn-Schmiedeberg's Arch. Pharmacol. 326, 69–74 (1984). https://doi.org/10.1007/BF00518781

Download citation

  • Received:

  • Accepted:

  • Issue Date:

  • DOI: https://doi.org/10.1007/BF00518781

Key words

Navigation